Delivery Order SPE2DB22D2206-SPE2DB25FKB48
Award Date 9/23/25
Potential Completion Date 10/15/25
Potential Value $7.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,327.94 to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela (1,600 mg-26,800 13.4ml) on September 10, 2025, with completion expected by October 1, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela (rituximab-hyaluronidase), a monoclonal antibody treatment, in the amount of $8,655.88 with an ultimate completion date of September 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Rituxan Hycela (rituximab and hyaluronidase), a specialty pharmaceutical product used in oncology and immunology treatment regimens. The contract is valued at $3,718.02 with a firm fixed price structure and an ultimate completion date of October 8, 2025. This delivery order is non-set-aside and was competitively awarded,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $29,744.16 firm fixed price delivery order on July 28, 2025, for the supply of Rituxan Hycela (1,400 mg-23,400 11.7 mL), a monoclonal antibody immunosuppressant used in treating rheumatoid arthritis and certain lymphomas. This non-set-aside competitive award will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,436.04 firm fixed price delivery order is for 1,400 mg-23,400 11.7 ml units of the medication Rituxan Hycela. The contract has a completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which provides a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,718.02, is for the supply of 1,400 mg-23,400 11.7 ml vials of the drug Rituxan Hycela. The contract is a firm fixed price agreement and has an ultimate completion date of February 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $3,718.02, is for the delivery of Rituxan Hycela 1,400 mg-23,400 11.7 ml. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 21, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Rituxan Hycela, a 1,400 mg-23,400 11.7 mL medication, with a ceiling value of $7,436.04. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) worth $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,741,919 units of the pharmaceutical product Rituxan Hycela 1,600 mg-26,800 13.4 mL. The award has a potential value of $4,167.13 and a completion date of March 14, 2024. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp serves as the prime contractor,...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $29,254.08 firm fixed price contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug RITUXAN HYCELA. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through...